NIOSH testimony on occupational exposure to 1,3-butadiene by J. D. Millar, November 26, 1991.
Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, 1991 Nov; :1-14
These post hearing comments summarized the viewpoint of NIOSH concerning exposure to 1,3-butadiene (106990) at the workplace. Issues discussed included: repair of leaks to reduce exposures; remote sensing devices to alert workers of leakage; sampling of process streams; engineering controls, the proportion of equipment that would have to be retrofitted to meet airborne concentrations less than 2 parts per million; closed loop sampling in polymer facilities; the feasibility of reducing 1,3-butadiene exposures to the 1 part per million level; pharmacokinetic risk assessment; organic vapor cartridge breakthrough times and service life; fit testing; engineering feasibility assessments to determine whether engineering controls are feasible; epidemiological studies of lymphatic and hematopoietic neoplasms in 1,3-butadiene exposed workers; field studies; medical surveillance; and the frequency of exposure monitoring.
NIOSH-Author; NIOSH-Testimony; Millar-J-D; Dienes; Workplace-studies; Occupational-exposure; Industrial-hygiene; Control-technology; Risk-analysis; Respiratory-protective-equipment; Epidemiology; Medical-monitoring
NTIS Accession No.
National Institute for Occupational Safety and Health